Loading clinical trials...
Loading clinical trials...
Effectiveness and Safety of Intracavernosal Administration of Autologous Adipose-Derived Regenerative Cells for Treatment of Erectile Dysfunction
Conditions
Interventions
Intracavernosal administration of autologous ADRC
Liposuction
+1 more
Locations
2
Russia
I.M. Sechenov First Moscow State Medical University
Moscow, Russia
Federal State Budgetary Institution "Central Clinical Hospital with Outpatient Health Center" of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies
Moscow, Russia
Start Date
April 1, 2015
Primary Completion Date
November 1, 2016
Completion Date
November 1, 2016
Last Updated
November 30, 2016
NCT07480161
NCT07460960
NCT07431008
NCT06167733
NCT06968494
NCT06605508
Lead Sponsor
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions